Overview
Dabigatran is the active form of the orally bioavailable prodrug dabigatran etexilate.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/04/25 | Phase 1 | Recruiting | |||
2025/02/10 | Phase 2 | Not yet recruiting | |||
2024/10/21 | Phase 4 | Not yet recruiting | Emily McDonald | ||
2024/08/13 | Phase 3 | Recruiting | |||
2024/08/13 | Phase 3 | Recruiting | |||
2024/06/10 | Not Applicable | Active, not recruiting | |||
2024/06/04 | Phase 1 | Not yet recruiting | International Bio service | ||
2024/04/29 | N/A | Not yet recruiting | The Affiliated Hospital Of Guizhou Medical University | ||
2023/05/01 | N/A | Completed | |||
2023/03/28 | Phase 1 | Terminated |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | 59651-973 | ORAL | 75 mg in 1 1 | 5/15/2025 | |
| Bryant Ranch Prepack | 63629-8242 | ORAL | 150 mg in 1 1 | 6/25/2021 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 0597-0450 | ORAL | 150 mg in 1 1 | 11/27/2023 | |
| Boehringer Ingelheim Pharmaceuticals Inc. | 0597-0108 | ORAL | 110 mg in 1 1 | 11/28/2023 | |
| Camber Pharmaceuticals, Inc. | 31722-622 | ORAL | 150 mg in 1 1 | 7/8/2023 | |
| Aurobindo Pharma Limited | 59651-974 | ORAL | 110 mg in 1 1 | 5/15/2025 | |
| A-S Medication Solutions | 50090-3617 | ORAL | 150 mg in 1 1 | 4/23/2021 | |
| Camber Pharmaceuticals, Inc. | 31722-621 | ORAL | 75 mg in 1 1 | 7/8/2023 | |
| American Health Packaging | 60687-744 | ORAL | 75 mg in 1 1 | 3/30/2023 | |
| XLCare Pharmaceuticals, Inc. | 72865-273 | ORAL | 150 mg in 1 1 | 7/26/2023 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.